2022 - Research.com Medicine in Norway Leader Award
His primary scientific interests are in Genome-wide association study, Genetics, Schizophrenia, Bipolar disorder and Single-nucleotide polymorphism. His Genome-wide association study research includes themes of Odds ratio, Disease, Genetic association, Genetic variation and Genetic architecture. His work on Genetics is being expanded to include thematically relevant topics such as Case-control study.
His Schizophrenia research is multidisciplinary, incorporating elements of Psychosis, Internal medicine, Severity of illness, Risk factor and Neuroscience. His Bipolar disorder research integrates issues from Major depressive disorder and Clinical psychology. The study incorporates disciplines such as Alzheimer's disease, Body mass index, Bioinformatics and Genetic epidemiology in addition to Single-nucleotide polymorphism.
Ole A. Andreassen focuses on Schizophrenia, Bipolar disorder, Genome-wide association study, Psychiatry and Genetics. His Schizophrenia research incorporates themes from Psychosis, Neuroscience, Internal medicine and Clinical psychology. His Internal medicine research is multidisciplinary, relying on both Oncology and Antipsychotic.
His study in Clinical psychology is interdisciplinary in nature, drawing from both Neurocognitive, Cognition and Anxiety. His Bipolar disorder study combines topics in areas such as Major depressive disorder, Neuroimaging, Pediatrics and Mood. As part of one scientific family, Ole A. Andreassen deals mainly with the area of Genome-wide association study, narrowing it down to issues related to the Genetic association, and often Computational biology.
His scientific interests lie mostly in Schizophrenia, Bipolar disorder, Internal medicine, Clinical psychology and Genome-wide association study. His Schizophrenia research is multidisciplinary, incorporating perspectives in White matter, Fractional anisotropy, Etiology, Psychosis and Pediatrics. He combines subjects such as Major depressive disorder, Neuroimaging and Mood with his study of Bipolar disorder.
His research in Internal medicine intersects with topics in Endocrinology and Oncology. In Clinical psychology, Ole A. Andreassen works on issues like Cognition, which are connected to Human brain. His Genome-wide association study study integrates concerns from other disciplines, such as Expression quantitative trait loci, Genetic association and Genetic architecture.
Schizophrenia, Bipolar disorder, Neuroimaging, Genome-wide association study and Internal medicine are his primary areas of study. He has researched Schizophrenia in several fields, including White matter, Magnetic resonance imaging, Psychosis, Autism and Clinical psychology. Ole A. Andreassen has included themes like Gene expression, Audiology, Mood, Major depressive disorder and Risk factor in his Bipolar disorder study.
His studies deal with areas such as Biobank, Brain morphometry, Genetic association and Genetic architecture as well as Genome-wide association study. His Internal medicine research is multidisciplinary, incorporating elements of Endocrinology, Oncology and Cardiology. His Gene study results in a more complete grasp of Genetics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Biological insights from 108 schizophrenia-associated genetic loci
Stephan Ripke;Stephan Ripke;Benjamin M. Neale;Benjamin M. Neale;Aiden Corvin;James T. R. Walters.
Large recurrent microdeletions associated with schizophrenia
Hreinn Stefansson;Dan Rujescu;Sven Cichon;Olli P. H. Pietilainen.
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs
S. Hong Lee;Stephan Ripke;Stephan Ripke;Benjamin M. Neale;Benjamin M. Neale;Stephen V. Faraone.
Nature Genetics (2013)
Common variants conferring risk of schizophrenia
Hreinn Stefansson;Hreinn Stefansson;Roel A. Ophoff;Roel A. Ophoff;Roel A. Ophoff;Stacy Steinberg;Stacy Steinberg;Ole A. Andreassen.
Variant of TREM2 associated with the risk of Alzheimer's disease
Thorlakur Jonsson;Hreinn Stefansson;Stacy Steinberg;Ingileif Jonsdottir.
The New England Journal of Medicine (2013)
Genome-wide association study identifies five new schizophrenia loci
Stephan Ripke;Alan R. Sanders;Kenneth S. Kendler;Douglas F. Levinson.
Nature Genetics (2011)
A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
Thorlakur Jonsson;Jasvinder K. Atwal;Stacy Steinberg;Jon Snaedal.
Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4
Pamela Sklar;Pamela Sklar;Stephan Ripke;Stephan Ripke;Laura J. Scott;Ole A. Andreassen.
Nature Genetics (2011)
Mice Deficient in Cellular Glutathione Peroxidase Show Increased Vulnerability to Malonate, 3-Nitropropionic Acid, and 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine
Peter Klivenyi;Ole A. Andreassen;Robert J. Ferrante;Alpaslan Dedeoglu.
The Journal of Neuroscience (2000)
Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis
P Klivenyi;R J Ferrante;R J Ferrante;R T Matthews;M B Bogdanov.
Nature Medicine (1999)
European Journal of Pharmacology
(Impact Factor: 5.195)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: